Recent Searches

    World’s first medical-grade vapouriser now available in the UK

    By

    The world’s first medical-grade vapouriser – the VapePod – is now available to UK customers. 

    Customers in the UK can now purchase Kanabo’s VapePod on Handpicked CBD, which enables tracking of exactly how much CBD is best using metered dosing.

    UK-based Kanabo, which has carried out extensive R&D in order to develop innovative medical-grade vapourisers and various non-smoking consumption solutions, has enabled the vape to be used with its three new proprietary formulas: Reload, Relax and Repair.

    The high-quality pure hemp distillate CBD formulas contain up to 86% cannabinoids and the vapourisation of CBD means it is fast-acting compared to other products like tinctures or edibles. Each cartridge that goes into the VapePod contains 360mg of CBD and has a blend of terpenes, give more than 300 doses lasting between six to eight weeks.

    [irp posts=”1187″ name=”Kanabo acquires slice of Hellenic Dynamics ahead of London Stock Exchange listing”]

    Kanabo CEO, Avihu Tamir commented: “We are delighted to offer our CBD wellness line through Handpicked CBD. 

    “Consumers now have access to the strongest yet non-intoxicating CBD formulas with only the highest quality of ingredients. Kanabo’s R&D team has created these fast-acting formulas with the health and wellness of consumers in mind.”

    HandPickedCBD, a Materia asset, currently features more than 50 brands and more than 500 different products, all of which must satisfy a list of quality and safety criteria before they are featured on the platform. It is The Marketplace for the best of all CBD products available online in the UK. 

    [irp posts=”1462″ name=”Cannabis firm Kanabo appoints Tory MP Dr Daniel Poulter MP to the board”]

    The platform highlights the benefit of the proposed partnership between Kanabo and Materia that will make Kanabo the largest medicinal cannabis company in Europe.

    [irp posts=”1841″ name=”Kanabo and Materia: innovating the cannabis supply chain in Europe”]

    Kanabo intends to add more to its portfolio of products as the brand grows.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.